Shibata S. A drug over the millennia: pharmacognosy, chemistry, and pharmacology of licorice[J]. Yakugaku Zasshi, 2000, 120(10): 849.
[2]
Fiore C, Eisenhut M, Ragazzi E, et al. A history of the therapeutic use of liquorice in Europe[J]. J Ethnopharmacol, 2005, 99(3): 317.
[3]
Hoever G, Baltina L, Michaelis M, et al. Antiviral activity of glycyrrhizic acid derivatives against SARS-coronavirus[J]. J Med Chem, 2005, 48(4): 1256.
[4]
Yamaguchi H, Noshita T, Yu T, et al. Novel effects of glycyrrhetinic acid on the central nervous system tumorigenic progenitor cells: induction of actin disruption and tumor cell-selective toxicity[J]. Eur J Med Chem, 2010, 45(7): 2943.
[5]
Yu T, Yamaguchi H, Noshita T, et al. Selective cytotoxicity of glycyrrhetinic acid against tumorigenic r/m HM-SFME-1 cells: potential involvement of H-Ras downregulation[J]. Toxicol Lett, 2010, 192(3): 425.
[6]
Csuk R, Schwarz S, Kluge R, et al. Synthesis and biological activity of some antitumor active derivatives from glycyrrhetinic acid[J]. Eur J Med Chem, 2010, 45(12): 5718.
[7]
Schwarz S, Csuk R. Synthesis and antitumour activity of glycyrrhetinic acid derivatives[J]. Bioorg Med Chem, 2010, 18(21): 7458.
[8]
Lai Y, Shen L, Zhang Z, et al. Synthesis and biological evaluation of furoxan-based nitric oxide-releasing derivatives of glycyrrhetinic acid as anti-hepatocellular carcinoma agents[J]. Bioorg Med Chem Lett, 2010, 20(22): 6416.
[9]
Gao Y, Guo X, Li X, et al. The synthesis of glycyrrhetinic acid derivatives containing a nitrogen heterocycle and their antiproliferative effects in human leukemia cells [J]. Molecules, 2010, 15(6): 4439.
[10]
Chadalapaka G, Jutooru I, Mcalees A, et al. Structure-dependent inhibition of bladder and pancreatic cancer cell growth by 2-substituted glycyrrhetinic and ursolic acid derivatives[J]. Bioorg Med Chem Lett, 2008, 18(8): 2633.
[11]
Liu D, Song D, Guo G, et al. The synthesis of 18beta-glycyrrhetinic acid derivatives which have increased antiproliferative and apoptotic effects in leukemia cells[J]. Bioorg Med Chem, 2007, 15(16): 5432.
[12]
Nishino H, Yoshioka K, Iwashima A, et al. Glycyrrhetic acid inhibits tumor-promoting activity of teleocidin and 12-O-tetradecanoyl -phorbol-13-acetate in two-stage mouse skin carcinogenesis[J]. Jpn J Cancer Res, 1986, 77(1): 33.
[13]
Agarwal M K, Iqbal M, Athar M. Inhibitory effect of 18beta-glycyrrhetinic acid on 12-O-tetradecanoylphorbol-13-acetate-induced cutaneous oxidative stress and tumor promotion in mice[J]. Redox Rep, 2005, 10(3): 151.
[14]
Satomi Y, Nishino H, Shibata S. Glycyrrhetinic acid and related compounds induce G1 arrest and apoptosis in human hepatocellular carcinoma HepG2[J]. Anticancer Res, 2005, 25(6B): 4043.
Hibasami H, Iwase H, Yoshioka K, et al. Glycyrrhetic acid (a metabolic substance and aglycon of glycyrrhizin) induces apoptosis in human hepatoma, promyelotic leukemia and stomach cancer cells[J]. Int J Mol Med, 2006, 17(2): 215.
[17]
Makino T, Tsubouchi R, Murakami K, et al. Generation of reactive oxygen species and induction of apoptosis of HL60 cells by ingredients of traditional herbal medicine, Sho-saiko-to[J]. Basic Clin Pharmacol Toxicol, 2006, 98(4): 401.
[18]
Lee C S, Kim Y J, Lee M S, et al. 18beta-Glycyrrhetinic acid induces apoptotic cell death in SiHa cells and exhibits a synergistic effect against antibiotic anti-cancer drug toxicity[J]. Life Sci, 2008, 83(13/14): 481.
[19]
Abe H, Ohya N, Yamamoto K F, et al. Effects of glycyrrhizin and glycyrrhetinic acid on growth and melanogenesis in cultured B16 melanoma cells[J]. Eur J Cancer Clin Oncol, 1987, 23(10): 1549.
Nabekura T, Yamaki T, Ueno K, et al. Inhibition of P-glycoprotein and multidrug resistance protein 1 by dietary phytochemicals.[J]. Cancer Chemother Pharmacol, 2008, 62(5): 867.
[32]
Lee C S, Yang J C, Kim Y J, et al. 18beta-Glycyrrhetinic acid potentiates apoptotic effect of trichostatin A on human epithelial ovarian carcinoma cell lines.[J]. Eur J Pharmacol, 2010, 649(1/3): 354.
[33]
Fujita M, Hayashi I, Yamashina S, et al. Blockade of angiotensin AT1a receptor signaling reduces tumor growth, angiogenesis, and metastasis.[J]. Biochem Biophys Res Commun, 2002, 294(2): 441.
[34]
Tanaka S, Sugimachi K, Yamashita Y, et al. Angiogenic switch as a molecular target of malignant tumors.[J]. J Gastroenterol, 2003, 38(Suppl 15): 93.
